Publications by authors named "Roberto Nilo"

Claim this Profile
M
Metabolic dysfunction-associated steatotic liver disease, insulin resistance and hepatocellular carcinoma: A deadly triad.
Alfredo Caturano, Enes Erul, Roberto Nilo, Davide Nilo, Vincenzo Russo

Eur J Clin Invest· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Insulin resistance and cancer: molecular links and clinical perspectives.
Alfredo Caturano, Enes Erul, Roberto Nilo, Davide Nilo, Vincenzo Russo

Mol Cell Biochem· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Editorial on: Canagliflozin Mediates Mitophagy Through the AMPK/PINK1/PARKIN Pathway to Alleviate Isoprenaline-Induced Cardiac Remodeling.
Alfredo Caturano, Davide Nilo, Roberto Nilo, Vincenzo Russo, Marcellino Monda

J Cardiovasc Pharmacol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Advances in Nanomedicine for Precision Insulin Delivery.
Alfredo Caturano, Roberto Nilo, Davide Nilo, Vincenzo Russo, Erica Santonastaso

Pharmaceuticals (Basel)· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tissue Inhibitor of Metalloproteinases-1 Overexpression Mediates Chemoresistance in Triple-Negative Breast Cancer Cells.
Lisa Agnello, Annachiara d'Argenio, Alessandra Caliendo, Roberto Nilo, Antonella Zannetti

Cells· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Aptamer-Based Strategies to Boost Immunotherapy in TNBC.
Lisa Agnello, Annachiara d'Argenio, Roberto Nilo, Monica Fedele, Simona Camorani

Cancers (Basel)· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Aptamer-Functionalized Nanoparticles Mediate PD-L1 siRNA Delivery for Effective Gene Silencing in Triple-Negative Breast Cancer Cells.
Simona Camorani, Silvia Tortorella, Lisa Agnello, Chiara Spanu, Annachiara d'Argenio, Roberto Nilo

Pharmaceutics· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimization of Short RNA Aptamers for TNBC Cell Targeting.
Simona Camorani, Annachiara d'Argenio, Lisa Agnello, Roberto Nilo, Antonella Zannetti

Int J Mol Sci· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis